The report of the main topics highlighted at the event on 12 October 2022 related to Probiotics, Prebiotics and the Microbiome.
The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.
Formal approval of BiomeBank’s first-generation donor derived microbiome-based therapy product, BIOMICTRA registered in the Australian Register of Therapeutic Goods
The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.
A supplement of LGG would seem to favour the proliferation of Bifidobacterium and the improvement of clinical and immunological response to childhood cystic fibrosis.
Healthy, diabetic, and obese people compared on diet and lifestyle using innovative technologies and multi-omics analysis
Researchers found that the microbiota of the recipient, rather than that of the donor, determines the microbial mix resulting from a fecal transplant.
New studies provide evidence that there may be fungi within tumors and could also help to diagnose certain types of cancer or predicting their course.
Moraxella may be involved in protecting children from COVID-19 infections through its action on amino acid and lipid metabolism in the upper respiratory tract.
The findings of a new research could help to optimize fecal microbiota transplantation (FMT) protocols and identify the most suitable donors for transplantation.
